Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02879253
Other study ID # P/2015/280
Secondary ID
Status Completed
Phase N/A
First received August 10, 2016
Last updated August 9, 2017
Start date December 24, 2015
Est. completion date July 11, 2016

Study information

Verified date August 2017
Source Centre Hospitalier Universitaire de Besancon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is part of the french research program ANR NEMRO "MICROROBOTIC NASAL ENDOSCOPY BY OPTICAL COHERENCE TOMOGRAPHY: IMPACT OF SMELL DEFICIENCY ON NEURODEGENERATIVE DISEASES." Recent studies have shown a strong correlation between the decrease in olfactory faculties of patients and the presence of neurodegenerative diseases.

This possible relationship has created a need to inspect in detail the area of the nasal cavity that houses the olfactory function.

Thus, the purpose of NEMRO project is developing a robot to explore olfactory slots of patients, with a view to extract images through non invasive imaging probe, and hoping to identify early signs of degeneration the olfactory tissue. The robot developed will thus be able to navigate in the nasal cavity of patients, and to break into the olfactory slots, which will host the imaging phase.

The purpose of this study is therefore to collect data on the usual path of instruments (endoscope, for example) in this area, and future potential pathway of the robot. This collection made from Computed Tomography (CT) scans will define the clinical geometry of the target area and provide precisely the dimensional constraints needed to build the NEMRO robot .


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date July 11, 2016
Est. primary completion date July 11, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- men or women aged >18

Exclusion Criteria:

- any pathology observed on the scan (sinusitis, cancer, previous surgery ...), that could interfere with the evaluated parameters, according to the medical expert

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHU Besançon Besançon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Width of the nasal cavity and olfactory slots Distance measurements to evaluate the width of the nasal cavity and olfactory slots, on previous available imaging. Composite primary outcome. at enrollment
Primary Geometry of the nasal cavity and olfactory slots Assesment of the geometry of the nasal cavity and olfactory slots, on previous available imaging. Composite primary outcome. at enrollment